CVE-2026-44115: OpenClaw before 2026.4.22 contains an exec allowlist analysis vulnerability allowing shell expansion
Source GCVE Database
Not known to be exploited · CVSS 8.8 High.
Data as of 27 Oct 2026, 00:07 UTC
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:HExploitation evidence
Disclosed: evidence found.
CVE published 6 May 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.
Description
OpenClaw before 2026.4.22 contains an exec allowlist analysis vulnerability allowing shell expansion hiding in unquoted heredoc bodies. Attackers can bypass allowlist validation by embedding shell expansion tokens in heredoc bodies to execute unapproved commands at runtime.
References
- github.com/openclaw/openclaw/security/advisories/GHSA-x3h8-jrgh-p8jx (opens in a new tab)
- nvd.nist.gov/vuln/detail/CVE-2026-44115 (opens in a new tab)
- github.com/openclaw/openclaw/commit/b2e8b7d4bb2f22eaa16f5c4b07547774e90b65a5 (opens in a new tab)
- vulncheck.com/advisories/openclaw-shell-expansion-bypass-in-unquoted-heredocs-via-exec-allowlist (opens in a new tab)